Skip to main content
CERS
NASDAQ Life Sciences

Cerus Q4收入超出预期11%,净利润220万美元

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$2.52
Mkt Cap
$485.981M
52W Low
$1.12
52W High
$2.955
Market data snapshot near publication time

summarizeSummary

Cerus Corp报告了强劲的第四季度业绩,收入达到6460万美元,大幅超过IBES预估的5810万美元。该公司还报告了220万美元的净利润和340万美元的调整EBITDA,以及2970万美元的毛利。另外,Cerus提供了全年收入预测为2.24亿至2.28亿美元。这一积极的盈利惊喜和坚实的指导对股票有重要意义,表明运营表现优于预期,并可能推动投资者信心。交易者可能会对收入超出预期和盈利季度做出积极反应。

在该公告发布时,CERS的交易价格为$2.52,交易所为NASDAQ,所属行业为Life Sciences,市值约为$4.9亿。 52周交易区间为$1.12至$2.96。 这则新闻被评估为积极市场情绪,重要性评分为8/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed CERS - Latest Insights

CERS
Apr 22, 2026, 12:01 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CERS
Apr 22, 2026, 12:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CERS
Apr 21, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
CERS
Mar 16, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
CERS
Mar 02, 2026, 5:03 PM EST
Filing Type: 10-K
Importance Score:
7
CERS
Mar 02, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
CERS
Mar 02, 2026, 4:01 PM EST
Source: Reuters
Importance Score:
8
CERS
Jan 12, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7